ÂÜÀòÂÒÂ×

Bryan Fioret is a Senior Scientist at United Therapeutics Corporation, where responsibilities include conducting research to develop tissue-based regenerative medicine products for pulmonary hypertension and other lung diseases since December 2016. Prior experience includes a Postdoctoral Fellow position at Duke University, focusing on the interactions between lung epithelial cells and their extracellular matrix, and a Graduate Student role at Vanderbilt University, where characterization of endothelial-derived cardiac progenitor cells was undertaken. Additionally, a Research Assistant position at the University of Louisville involved studying the effects of Sphingosine Kinase on cell survival and proliferation. Bryan Fioret holds a PhD in Cell/Cellular and Molecular Biology from Vanderbilt University and a BS in Biochemistry and Molecular Biology from Centre College.